Get the Stockscreener App
5.09
0.59%
0.03
Sonoma Pharmaceuticals Inc stock is traded at $5.09, with a volume of 156.18K.
It is up +0.59% in the last 24 hours and up +43.18% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$5.06
Open:
$5.06
24h Volume:
156.18K
Relative Volume:
0.13
Market Cap:
$8.36M
Revenue:
$12.31M
Net Income/Loss:
$-5.08M
P/E Ratio:
-5.4149
EPS:
-0.94
Net Cash Flow:
$-5.20M
1W Performance:
-4.86%
1M Performance:
+43.18%
6M Performance:
+112.53%
1Y Performance:
+10.51%
1-Day Range:
$4.75
$5.18
1-Week Range:
$4.75
$5.60
52-Week Range:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
5.09 | 8.79M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
How to monitor Sonoma Pharmaceuticals Inc. with trend dashboardsTrade Risk Assessment & Fast Moving Stock Trade Plans - Newser
Sonoma Pharmaceuticals Inc. stock chart pattern explainedQuarterly Portfolio Report & Fast Momentum Entry Tips - Newser
Relative strength of Sonoma Pharmaceuticals Inc. in sector analysis2025 Big Picture & Entry and Exit Point Strategies - Newser
What moving averages say about Sonoma Pharmaceuticals Inc.July 2025 WrapUp & Reliable Entry Point Trade Alerts - Newser
Combining machine learning predictions for Sonoma Pharmaceuticals Inc.2025 Trading Recap & Fast Gaining Stock Strategy Reports - Newser
Is Sonoma Pharmaceuticals Inc. still worth holding after the dip2025 Sector Review & Technical Confirmation Trade Alerts - Newser
Has Sonoma Pharmaceuticals Inc. found a price floorQuarterly Risk Review & Low Risk High Reward Ideas - Newser
Long term hold vs stop loss in Sonoma Pharmaceuticals Inc.Forecast Cut & AI Enhanced Trade Execution Alerts - Newser
Is Sonoma Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Earnings & Long Hold Capital Preservation Tips - Newser
When is the best time to exit Sonoma Pharmaceuticals Inc.Quarterly Performance Summary & Daily Market Momentum Tracking - Newser
Published on: 2025-08-19 15:39:20 - Newser
Custom strategy builders for tracking Sonoma Pharmaceuticals Inc.Weekly Stock Analysis & Low Risk Growth Stock Ideas - Newser
What’s next for Sonoma Pharmaceuticals Inc. stock priceJuly 2025 Review & Weekly High Potential Stock Alerts - Newser
Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock - Yahoo Finance
Applying Wyckoff theory to Sonoma Pharmaceuticals Inc. stock2025 Market Trends & Daily Growth Stock Investment Tips - Newser
Quantitative breakdown of Sonoma Pharmaceuticals Inc. recent moveGap Up & Free Technical Confirmation Trade Alerts - Newser
Understanding Sonoma Pharmaceuticals Inc.’s price movement2025 Technical Overview & Growth Focused Stock Reports - Newser
Advanced analytics toolkit walkthrough for Sonoma Pharmaceuticals Inc.Quarterly Growth Report & Consistent Profit Trading Strategies - Newser
Is Sonoma Pharmaceuticals Inc. Stock Overbought or Oversold RSI Indicator AnalysisJuly 2025 Catalysts & AI Forecast for Swing Trade Picks - Newser
What’s the recovery path for long term holders of Sonoma Pharmaceuticals Inc.July 2025 Reactions & Technical Entry and Exit Alerts - Newser
Tools to monitor Sonoma Pharmaceuticals Inc. recovery probabilityMarket Activity Report & High Accuracy Investment Signals - Newser
Can technical indicators confirm Sonoma Pharmaceuticals Inc.’s reversalJuly 2025 Institutional & Verified Trade Idea Suggestions - Newser
Price Channel Expanding on Sonoma Pharmaceuticals Inc.’s ChartJuly 2025 Institutional & Daily Entry Point Alerts - sundaytimes.kr
Should you wait for a breakout in Sonoma Pharmaceuticals Inc.Inflation Watch & Weekly Momentum Stock Picks - Newser
Will Sonoma Pharmaceuticals Inc. stock split in the near futureJuly 2025 Highlights & Low Risk Entry Point Tips - Newser
How to build a dashboard for Sonoma Pharmaceuticals Inc. stockJuly 2025 Short Interest & Entry Point Confirmation Alerts - Newser
Is this a good reentry point in Sonoma Pharmaceuticals Inc.Analyst Upgrade & Growth Oriented Trading Recommendations - Newser
Live Chart Scan Detects Wedge Pattern in Sonoma Pharmaceuticals Inc.Dividend Hike & Weekly High Conviction Trade Ideas - 선데이타임즈
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):